David Liu
0000-0003-0346-5033
Publication & Citation Trends
Publications
579 total
Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models OA
Cited by 8
Semantic Scholar
Molecular and genomic characterisation of a panel of human anal cancer cell lines OA
Cited by 6
Semantic Scholar
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma OA
Cited by 16
Semantic Scholar
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma PDF
Cited by 1,071
OpenAlex
Abstract 4618: A novelPik3ca-driven mouse model and syngeneic cancer cell line for the preclinical testing of targeted and immune therapies for anal squamous cell carcinoma (ASCC) OA
Cited by 0
Semantic Scholar
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade PDF
Cited by 1,412
OpenAlex
PS02.194: THE GENERATION & VALIDATION OF FOUR NEW ESOPHAGEAL CANCER CELL LINES WITH MATCHED PATIENT-DERIVED TUMOR XENOGRAFTS
Cited by 0
Semantic Scholar
Tumor-Infiltrating Lymphocyte Function Predicts Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. OA
Cited by 69
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(126)
Cancer Immunotherapy and Biomarkers
(77)
Bioinformatics and Genomic Networks
(47)
Genetics, Bioinformatics, and Biomedical Research
(42)
Immunotherapy and Immune Responses
(39)
Affiliations
The Wistar Institute
Broad Institute
Stevens Institute of Technology
Pasadena City College
Boston University